Skip to main content

Namzaric Side Effects

Generic name: donepezil / memantine

Medically reviewed by Drugs.com. Last updated on Nov 12, 2023.

Note: This document contains side effect information about donepezil / memantine. Some dosage forms listed on this page may not apply to the brand name Namzaric.

Applies to donepezil / memantine: oral capsule extended release.

Serious side effects of Namzaric

Along with its needed effects, donepezil / memantine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking donepezil / memantine:

Incidence not known

Other side effects of Namzaric

Some side effects of donepezil / memantine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

For Healthcare Professionals

Applies to donepezil / memantine: oral capsule extended release, oral kit.

Cardiovascular

Memantine:

Common (1% to 10%): Hypertension, hypotension

Postmarketing reports: Congestive cardiac failure

Donepezil:

Common (1% to 10%): Hypertension, hemorrhage, syncope

Postmarketing reports: Heart block (all types)[Ref]

Nervous system

Memantine:

Common (1% to 10%): Headache, dizziness, somnolence

Donepezil:

Common (1% to 10%): Headache, dizziness, somnolence

Postmarketing reports: Convulsions, neuroleptic malignant syndrome[Ref]

Gastrointestinal

Memantine:

Common (1% to 10%): Diarrhea, constipation, abdominal pain, vomiting

Postmarketing reports: Pancreatitis

Donepezil:

Very common (10% or more): Diarrhea (10%)

Common (1% to 10%): Vomiting, anorexia, nausea

Postmarketing reports: Abdominal pain, pancreatitis[Ref]

Respiratory

Memantine:

Common (1% to 10%): Influenza[Ref]

General

The most common adverse reactions in patients receiving memantine ER were headache, diarrhea, and dizziness. The most common adverse reactions in patients receiving donepezil were diarrhea, anorexia, vomiting, nausea, and ecchymosis.[Ref]

Dermatologic

Memantine:

Postmarketing reports: Stevens Johnson Syndrome

Donepezil:

Common (1% to 10%): Eczema

Postmarketing reports: Rash[Ref]

Hematologic

Memantine:

Postmarketing reports: Agranulocytosis, leukopenia (including neutropenia), pancytopenia, thrombocytopenia, thrombotic thrombocytopenic purpura

Donepezil:

Common (1% to 10%): Ecchymosis

Postmarketing reports: Hemolytic anemia[Ref]

Hepatic

Memantine:

Postmarketing reports: Hepatitis

Donepezil:

Postmarketing reports: Cholecystitis, hepatitis[Ref]

Metabolic

Donepezil:

Common (1% to 10%): Increased creatinine phosphokinase, dehydration, hyperlipidemia

Postmarketing reports: Hyponatremia[Ref]

Musculoskeletal

Memantine:

Common (1% to 10%): Back pain

Donepezil:

Common (1% to 10%): Back pain[Ref]

Other

Memantine:

Common (1% to 10%): Increased weight

Donepezil:

Very common (10% or more): Accident (13%), infection (11%)

Common (1% to 10%): Fever, pain, chest pain[Ref]

Psychiatric

Memantine:

Common (1% to 10%): Anxiety, depression, aggression

Postmarketing reports: Suicidal ideation

Donepezil:

Common (1% to 10%): Insomnia, nervousness, hallucinations, hostility, depression, confusion, emotional lability, personality disorder

Postmarketing reports: Agitation, confusion, hallucinations[Ref]

Renal

Memantine:

Common (1% to 10%): Urinary incontinence

Postmarketing reports: Acute renal failure

Donepezil:

Common (1% to 10%): Urinary incontinence[Ref]

References

1. Product Information. Namzaric (donepezil-memantine). Forest Pharmaceuticals. 2015.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer